An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom

An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom

<b>Background</b>: In the United Kingdom (UK), a cell-based quadrivalent influenza vaccine (QIVc) and a recombinant vaccine (QIVr) are recommended for eligible adults under 65 years. The objective of this analysis was to determine the potential cost-effectiveness of QIVc compared to QIVr...

Full description

Bibliographic Details
Main Authors: Michael Maschio, Michele A. Kohli, Mansoor Ashraf, Michael F. Drummond, Milton C. Weinstein, Joaquin F. Mould-Quevedo
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Vaccines
Subjects:
influenza vaccine
cost-effectiveness
economic modeling
Online Access:https://www.mdpi.com/2076-393X/10/4/599

Internet

https://www.mdpi.com/2076-393X/10/4/599

Similar Items